{
    "2021-06-28": [
        [
            {
                "time": "2021-07-05",
                "original_text": "益丰药店：120.94万股限制性股票将于7月5日上市流通",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "限制性股票",
                        "上市流通"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-05",
                "original_text": "益丰药店（603939.SH）：120.939万股限制性股票将于7月5日上市流通",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "限制性股票",
                        "上市流通"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "益丰药店：实际控制人高毅累计质押股份数为470万股",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "实际控制人",
                        "高毅",
                        "质押"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "益丰药店（603939.SH）：实控人质押470万股",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "实控人",
                        "质押"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-05",
                "original_text": "益丰药店：约120.94万股限售股7月5日解禁，占比0.17% 解禁",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "限售股",
                        "解禁"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "叮当快药，生不逢时",
                "features": {
                    "keywords": [
                        "叮当快药",
                        "生不逢时"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021",
                "original_text": "2021年，药企全年业绩将持续向好",
                "features": {
                    "keywords": [
                        "药企",
                        "全年业绩",
                        "持续向好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "揭秘送转股168只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "除权",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "叮当快药IPO：三年多累亏4.3亿，阿里美团京东巨头环伺，即时送药是好赛道吗？ 亏损",
                "features": {
                    "keywords": [
                        "叮当快药",
                        "IPO",
                        "亏损",
                        "阿里",
                        "美团",
                        "京东",
                        "即时送药"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}